Schedule For DePuy MDL Postponed And Company President Resigns
Two events recently happened in the world of the DePuy ASR hip recall . First, Mindy Tinsley, spokesperson for DePuy Orthopaedics stated that its president, David Floyd, have resigned. His wish to “pursue outside interests” is a reason he tells for his resignation. A replacement is yet to be announced and Floyd is anticipated to leave the company soon.
Floyd’s reason for his departure leaves a lot to be desired. He has been president of the company since 2007. It is probable that Floyd has already known of the issues associated with both the ASR XL Acetabular System and the ASR Hip Resurfacing System and their apparent failure among recipients. He did not take the appropriate action to address the problems. The United States Food and Drugs Administration received about four hundred reports from recipients complaining about how the ASRs have caused them pain and suffering. Only when the public knew of how defective the hip replacement were did DePuy recall the products. It wasn’t until August 2010 that DePuy recalled the hip replacements.
Out of the 93,000 DePuy hip replacement devices sold worldwide, approximately 11,000 need a revision surgery. Complications from the recall include pain, limited or loss of mobility, dislocation, and metal toxicity resulting from metal debris getting flaked off from the device components. Cobalt and chromium poisoning could result in nerve damage.
The other piece of news is that in a court order dated March 4, David A. Katz, the federal judge presiding over the DePuy multidistrict litigation (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products (no. 1:10 md 2197)), postponed a March 9 status conference to April 5. Both parties involved would then be givent the chance to present an extensive plan related to pretrial discovery. The status conference will be held in West Palm Beach, Florida’s U.S. Courthouse.
These recent developments prove the the DePuy litigation is starting to take off in a positive way, at least for those who wish to gain compensation from the company. Some of it may be too much for company officials to digest causing them to make hasty decisions. Whatever the case may be, recipients of the ASRs and their lawyers alike are bent on making DePuy be held liable for the harm the devices have inflicted. For more information about the resignation of the DePuy president and the upcoming MDL conference , check out the DePuy ASR recall website.